Search for: "Takeda Pharmaceuticals International"
Results 21 - 40
of 69
Sorted by Relevance
|
Sort by Date
15 Apr 2016, 8:26 am
The study was published Jan. 11 in JAMA Internal Medicine. [read post]
1 Sep 2014, 7:04 am
. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
15 Feb 2013, 9:29 am
Cir. 2007)) (internal quotation marks omitted). [read post]
23 Apr 2009, 10:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Cepham – US: CAFC: Another ‘bright-line’ rule from the Federal Circuit; double jeopardy – later developments can overcome double patenting: Takeda Pharmaceutical Co v Doll (Patent Docs) (Patent Baristas) … [read post]
29 Mar 2011, 9:19 pm
New pharmaceutical compulsory licenses proposed for patented medicines (Patentology) (ipwars) Canada: Election drum beats the life out of Access to Medicines Bill (IP Osgoode) EU opines on the patentability of human embryonic stem cells: Brüstle v Greenpeace (Kluwer Patent Blog) (IPBiz) EU: In the ECJ this week: Case C-195/09 Synthon v Merz Pharma and Case C-427/09 Generics (UK) v Synaptech (The SPC Blog) India: The production of generic drugs in India: A new trade agreement with the… [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
25 May 2011, 4:59 am
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US:… [read post]
25 Apr 2017, 3:00 am
Baxter International v. [read post]
17 Feb 2012, 2:00 am
., where the issue was whether supplemental documents should be produced to comply with post-trial determination pursuant to DGCL Section 220 that books and records must be provided. 2) DealBook: Kodak Can Remove Name From Oscar Venue, Judge Rules – This post shares how lawyers for Eastman Kodak won bankruptcy court permission on Wednesday to cancel the company’s sponsorship agreement with the Los Angeles theater where the Oscars have been held for the last 10 years, in an attempt… [read post]
30 May 2010, 9:45 pm
The international drugmaker Takeda agreed to change the name of a heartburn drug Kapidex after there were reports that it was being confused with a prostate cancer drug. [read post]
28 Jul 2015, 11:52 am
Takeda Pharms. [read post]
6 Aug 2018, 11:50 am
Takeda’s internal safety research didn’t reflect these problems, leading some to question their methods. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
19 May 2010, 6:15 am
Lupin Pharmaceuticals, Inc. [read post]
5 Jun 2012, 12:10 pm
In that case, Bankosky had been a director in the business development group at Takeda Pharmaceuticals International, Inc. [read post]
2 Apr 2015, 7:32 am
Takeda Pharmaceuticals, Asia’s largest drugmaker, has offered to pay more than $2.2 billion to settle claims that it hid the cancer risks associated with its Actos diabetes medicine. [read post]
26 Apr 2021, 7:42 am
Moderna also entered into deals with Catalent Inc. and Baxter International Inc. to help fill vaccine vials, and Takeda will use an existing facility in Japan to manufacture, import, and distribute vaccines. [read post]
